Press Releases

WASHINGTON and VANCOUVER, British Columbia, Feb. 4, 2020 /PRNewswire/ -- Medicomp Systems, the leading provider of clinician-driven, point-of-care solutions that fix electronic health records (EHRs), and emtelligent™, a leader in structuring clinical text, announced today a strategic partnership to co-develop new

NEWPORT BEACH, Calif., Feb. 4, 2020 /PRNewswire/ -- Vital Data Technology, LLC, a leading health IT company serving the payer landscape, today announced the appointment of

AUBURN, Wash., Feb. 4, 2020 /PRNewswire/ -- Syntrix Pharmaceuticals announces the discovery that desmetramadol is a G-protein biased opioid receptor agonist.  The results, published in

DALLAS, Feb. 4, 2020 /PRNewswire/ -- This February, Eyemart Express, a leading national optical retailer and home of the fastest glasses in the industry, is showing appreciation to Oklahoman

NEW YORK, Feb. 4, 2020 /PRNewswire/ -- Osteoporosis is defined as a systemic skeletal disorder characterized by low bone mass, deterioration of bone tissue leading to enhanced bone fragility, and a consequent increase in fracture risk.  This asymptomat

MIAMI, Feb. 4, 2020 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 global life sciences companies, today announced it has made a number of new key leadership hires, with the express purpose of preparing for accelerated growth in North America,

SAN FRANCISCO and BOSTON, Feb. 4, 2020 /PRNewswire/ -- Trianni, Inc. ("TRIANNI") and Mablytics, Inc. ("MABLYTICS") jointly announced today that they have entered into a license agreement for the use of the Trianni Mouse®, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies, to support MABLYTICS'

GREENWICH, Conn., Feb. 4, 2020 /PRNewswire/ -- The Chan Zuckerberg Initiative (CZI) announced that the Fibrolamellar Cancer Foundation (FCF) is among a select group of patient-led rare disease organizations, including rare cancer foundations, to receive the first CZI Rare As One Network grant.

SANTA FE, NM, Feb. 4, 2020 /PRNewswire/ - Avisa Pharma Inc. ("AVISA" or "the Company"), a medical device company developing a drug/device biomarker technology platform that can detect virulent bacterial pathogens within minutes, today announced a three-year GBP £30 million (approximately $39.2 million USD) share subscription and drawd

EUGENE, Ore., Feb. 4, 2020 /PRNewswire/ -- Health & Safety Institute (HSI), a leader in Environmental Health and Safety (EHS) software, training and compliance solutions, today announced it has acquired leading safety and compliance management software platform, Donesafe.